FDA Approves Lilly's Zepbound To Treat Obstructive Sleep Apnea In Adults With Obesity
21/12 02:08
(RTTNews) - The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea or OSA in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity, Eli Lilly and Co...